Advertisement

Topics

BRIEF-Novartis says receives three new FDA approvals for expanded use of Ilaris treating rare periodic fever syndrome conditions

08:00 EDT 23 Sep 2016 | Reuters

* Says receives three new approvals from the U.S. Food and Drug Administration for expanded use of Ilaris treating rare periodic fever syndrome conditions.

Original Article: BRIEF-Novartis says receives three new FDA approvals for expanded use of Ilaris treating rare periodic fever syndrome conditions

NEXT ARTICLE

More From BioPortfolio on "BRIEF-Novartis says receives three new FDA approvals for expanded use of Ilaris treating rare periodic fever syndrome conditions"

Quick Search
Advertisement
 

Relevant Topics

Food
Food is any substance consumed to provide nutritional support for the body. It is usually of plant or animal origin, and contains essential nutrients, such as carbohydrates, fats, proteins, vitamins, or minerals. The substance is ingested by an organism ...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...